Biofrontera Stock Alpha and Beta Analysis

BFRI Stock  USD 0.76  0.02  2.56%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biofrontera. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biofrontera over a specified time horizon. Remember, high Biofrontera's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biofrontera's market risk premium analysis include:
Beta
(2.61)
Alpha
(0.12)
Risk
8.34
Sharpe Ratio
(0.03)
Expected Return
(0.22)
Please note that although Biofrontera alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Biofrontera did 0.12  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Biofrontera stock's relative risk over its benchmark. Biofrontera has a beta of 2.61  . As returns on the market increase, returns on owning Biofrontera are expected to decrease by larger amounts. On the other hand, during market turmoil, Biofrontera is expected to outperform it. As of now, Biofrontera's Book Value Per Share is increasing as compared to previous years. The Biofrontera's current Tangible Book Value Per Share is estimated to increase to 1.47, while Enterprise Value Over EBITDA is projected to decrease to (0.47).

Enterprise Value

7.92 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Biofrontera Backtesting, Biofrontera Valuation, Biofrontera Correlation, Biofrontera Hype Analysis, Biofrontera Volatility, Biofrontera History and analyze Biofrontera Performance.
For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.

Biofrontera Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biofrontera market risk premium is the additional return an investor will receive from holding Biofrontera long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biofrontera. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biofrontera's performance over market.
α-0.12   β-2.61

Biofrontera expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Biofrontera's Buy-and-hold return. Our buy-and-hold chart shows how Biofrontera performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Biofrontera Market Price Analysis

Market price analysis indicators help investors to evaluate how Biofrontera stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biofrontera shares will generate the highest return on investment. By understating and applying Biofrontera stock market price indicators, traders can identify Biofrontera position entry and exit signals to maximize returns.

Biofrontera Return and Market Media

The median price of Biofrontera for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 1.02 with a coefficient of variation of 18.98. The daily time series for the period is distributed with a sample standard deviation of 0.19, arithmetic mean of 1.02, and mean deviation of 0.17. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Biofrontera Inc Q2 2024 Earnings Call Highlights Strong Revenue Growth and Strategic ...
10/09/2024
2
Rosalind Advisors, Inc. Reduces Stake in Biofrontera Inc - Yahoo Finance
10/23/2024
3
Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz-Photodynamic Therapy Regarding The Treatment Of Superficial Basal Cell Carcinom...
10/31/2024
4
Ovid Therapeutics Reports Q3 Loss, Tops Revenue Estimates
11/12/2024
5
ARMISTICE CAPITAL, LLC Acquires New Stake in Biofrontera Inc
11/15/2024

About Biofrontera Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biofrontera or other stocks. Alpha measures the amount that position in Biofrontera has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Payables Turnover19.3611.881.941.84
Days Of Inventory On Hand127.7172.3228.24246.84

Biofrontera Upcoming Company Events

As portrayed in its financial statements, the presentation of Biofrontera's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biofrontera's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biofrontera's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biofrontera. Please utilize our Beneish M Score to check the likelihood of Biofrontera's management manipulating its earnings.
11th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Biofrontera

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Biofrontera offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biofrontera's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biofrontera Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biofrontera Stock:
Check out Biofrontera Backtesting, Biofrontera Valuation, Biofrontera Correlation, Biofrontera Hype Analysis, Biofrontera Volatility, Biofrontera History and analyze Biofrontera Performance.
For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Biofrontera technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biofrontera technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biofrontera trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...